Abstract
The effects of the acute administration of sodium-valproate (400 mg po) on plasma ACTH levels were studied in 4 patients with Cushing’s disease, 1 with Nelson’s syndrome and in 3 with Addison’s disease. No significant reduction of corticotropin concentration was observed, as compared to saline infusion. These data do not favor the hypothesis of an inhibitory role of sodium-valproate on ACTH secretion in such patients.
Similar content being viewed by others
References
Jones M.T., Gillham B., Beckford U., Donhorst A., Abraham R.R., Seed M., Wynn V. Effect of treatment with sodium-valproate and diazepam on plasma corticotropin in Nelson’s syndrome. Lancet 1: 1179, 1981.
Elias A.N., Gwinup G., Valenta L.J. Effects of valproic acid, naloxone and hydrocortisone in Nelson’s syndrome and Cushing’s disease. Clin. Endocrinol. (Oxf.) 15: 151, 1981.
Allolio B., Winkelmann W., Kaulen D., Hipp F.X., Mies R. Valproate in Cushing’s syndrome. Lancet 1: 171, 1982.
Perry T.L., Hansen S. Biochemical effects in man and rat of three drugs which can increase brain GABA content. J. Neurochem. 30: 679, 1978.
Jones M.T., Hillhouse E.W. Neurotransmitter regulation of corticotropin-releasing factor in vitro. Ann. N.Y. Acad. Sci. 297: 536, 1977.
Frascatani F., Muratori F., Loli P., Silvestrini F. Effetto delta somministrazione di Na-dipropilacetato in casi di m. di Cushing, s. di Nelson e m. di Addison. J. Endocrinol. Invest. 4 (suppl. 2): 84, 1981 (Abstract).
Acs Z., Stark E. Possible role of gamma-aminobutyric acid synthesis in the mechanism of dexamethasone feedback action. J. Endocrinol. 77: 137, 1978.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ambrosi, B., Bochicchio, D., Riva, E. et al. Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion. J Endocrinol Invest 6, 305–306 (1983). https://doi.org/10.1007/BF03347595
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347595